Clinical Trial Detail

NCT ID NCT03158883
Title UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Megan Daly, MD
Indications

lung non-small cell carcinoma

Therapies

Avelumab

Age Groups: adult senior

Additional content available in CKB BOOST